TIS tissue therapies limited

I think you have hit the nail on the head with those risks.TIS...

  1. 141 Posts.
    I think you have hit the nail on the head with those risks.
    TIS has had delays before. Changed regulatory processes, production contamination and government approval delays.
    Plus regular dilution issues, though less than most and now they reckon they can manage with the cash they have.
    The risks mean valueing it even at 10% of what is might be is still an optimistic call. But that means the upside is still huge if things work out.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.